Impact of Emotional Intelligence Awareness on Leadership Effectiveness in the Pharmaceutical Sector: A Systematic Review

Abstract

Emotional intelligence (EI) awareness is increasingly recognized as a critical leadership capability in complex and highly regulated sectors such as the pharmaceutical industry, where leaders must balance innovation, regulatory compliance, cross-functional collaboration, and workforce well-being. This systematic literature review (2019–2025) examines the influence of EI awareness on leadership effectiveness, with particular focus on communication, decision-making, conflict management, employee engagement, resilience, and team performance. The reviewed literature indicates that emotionally intelligent leaders demonstrate stronger transformational behaviors, enhanced trust-building, improved employee outcomes, and greater adaptability in high-pressure environments. Training-based studies confirm that EI is a developable competency; however, a persistent gap exists between awareness and its sustained application in practice. Sector-specific empirical research remains limited, particularly in the Indian context, and methodological rigor requires strengthening through longitudinal and intervention-based designs. Overall, EI awareness emerges as a strategically significant yet underutilized determinant of pharmaceutical leadership effectiveness, underscoring the need for targeted empirical research and structured leadership development initiatives.